Kayne Anderson Rudnick Investment Management LLC Guardant Health, Inc. Transaction History

Kayne Anderson Rudnick Investment Management LLC

$43.7 Billion
Q3 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$16.07 - $31.84 $80 - $159	5 New	5 $0
Q1 2021 May 17, 2021	SELL	$127.04 - $179.1 $381 - $537	-3 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$99.96 - $135.93 $299 - $407	3 New	3 $0

Others Institutions Holding GH

# of Institutions

327

Shares Held

127M

Call Options Held

843K

Put Options Held

2.37M

Vanguard Group Inc Valley Forge, PA

11.7M
Shares

$520 Million
0.0% of portfolio
Black Rock Inc. New York, NY

11.2M
Shares

$500 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

10.1M
Shares

$450 Million
0.04% of portfolio
Cadian Capital Management, LP New York, NY

6.93M
Shares

$308 Million
8.13% of portfolio
Deep Track Capital, LP Greenwich, CT

6M
Shares

$267 Million
5.07% of portfolio

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $4.55B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kayne Anderson Rudnick Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kayne Anderson Rudnick Investment Management LLC with notifications on news.

Account